Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600–Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials

IMPORTANCE: Prognostic models may provide insight into clinical trial results and inform the clinical management of patients with BRAF V600–mutated metastatic melanoma. OBJECTIVE: To identify subgroups with distinct survival outcomes based on clinical and genomic characteristics and to assess surviv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Oncol
Auteurs principaux: Hauschild, Axel, Larkin, James, Ribas, Antoni, Dréno, Brigitte, Flaherty, Keith T., Ascierto, Paolo A., Lewis, Karl D., McKenna, Edward, Zhu, Qian, Mun, Yong, McArthur, Grant A.
Format: Artigo
Langue:Inglês
Publié: American Medical Association 2018
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233771/
https://ncbi.nlm.nih.gov/pubmed/30073321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.2668
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires